“Based on the biologic properties of tebentafusp, a fusion protein, genetic toxicology studies are not warranted.”
✓ VerifiedFDA multi-discipline review, p. 45Source ↗
Carcinogenicity
Not conducted (advanced cancer indication)
“Carcinogenicity studies were not warranted for the proposed indication.”
✓ VerifiedFDA multi-discipline review, p. 46Source ↗
Reproductive & developmental
Not conducted (no relevant species); weight-of-evidence; FDA concluded possible fetal harm to skin, inner ear, eye
“Due to the specificity for human targets, embryo-fetal development (EFD) studies cannot be conducted in nonclinical species. Therefore, a weight of evidence assessment was conducted to evaluate the risk of tebentafusp administration on pregnancy and embryo-fetal development.”
✓ VerifiedFDA multi-discipline review, p. 46Source ↗
Safety pharmacology
Not conducted (no relevant species; in vitro only)
“Therefore, no specific safety pharmacology studies were conducted.”
✓ VerifiedFDA multi-discipline review, p. 42Source ↗